Advertisement
Screener

Biomea Fusion, Inc. (BMEA) Cash Flow Breakdown

Biomea Fusion, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Biomea Fusion, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $70.37M went out.
  • Fiscal year ended 2025-12-31: from financing, $67.90M came in.
  • Fiscal year ended 2025-12-31: change in cash, $2.47M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$70.37M$4.91M$63.00M*-$2.47M
2024-12-31-$119.89M-$362.00K$1.67M*-$118.59M
2023-12-31-$96.59M-$2.22M$161.80M$2.00M*$64.99M
2022-12-31-$62.42M$27.34M$1.24M*-$33.84M
2021-12-31-$35.44M-$33.35M$153.19M*$84.39M
2020-12-31-$4.46M-$51.00K$10.19M$55.77M*$61.46M
2019-12-31-$1.28M$1.44M$161.00K

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$10.03M*$0.00*
2026-03-31-$11.67M$550.00K-$11.12M
2025-12-31-$13.94M*-$124.00K*$23.24M*
2025-09-30-$11.55M*$0.00*$0.00*$1.97M*
2025-06-30-$19.21M*$0.00*$1.77M*$37.80M*
2025-03-31-$25.67M$0.00$3.26M-$22.41M
2024-12-31-$30.00M*-$82.00K*
2024-09-30-$25.22M*-$186.00K*$0.00*
2024-06-30-$32.64M*-$59.00K*$0.00*$1.07M*
2024-03-31-$32.03M-$35.00K$0.00-$31.95M
2023-12-31-$22.84M*-$8.00K*$622.00K*
2023-09-30-$23.90M*-$39.00K*
2023-06-30-$25.81M*-$417.00K*$162.84M*
2023-03-31-$24.04M-$1.76M$201.00K-$25.60M
2022-12-31-$20.20M*-$701.00K*
2022-09-30-$16.80M*$225.00K*
2022-06-30-$15.43M*$7.38M*
2022-03-31-$9.99M$20.44M$31.00K$10.48M
2021-12-31-$15.90M*$4.55M*
2021-09-30-$8.99M*-$75.00K*$0.00*
2021-06-30-$6.48M*$680.00K*$152.94M*
2021-03-31-$4.08M-$38.51M-$42.59M
2020-12-31-$2.74M*-$39.00K*$650.00K*$55.74M*
2020-09-30-$1.10M*-$68.00K*
2020-06-30-$369.00K*$9.56M*
2020-03-31-$252.00K$50.00K-$202.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
Equillium, Inc. (EQ)United States$0.109B-11.27
GENELUX Corp (GNLX)United States$0.110B-3.83
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
ProMIS Neurosciences Inc. (PMN)$0.102B
Quantum Cyber N.V. (QUCY)$0.113B
Immuneering Corp (IMRX)United States$0.113B-12.51
Milestone Pharmaceuticals Inc. (MIST)$0.098B-2.00
CITIUS ONCOLOGY, INC. (CTOR)United States$0.097B-1.49
Anixa Biosciences Inc (ANIX)United States$0.096B